Clin2
NCT07455058Worth exploringRecruiting

Water Vapor Ablation for Prostate Cancer Long-Term Registry

Prostate Cancer

Part of Cancer, Kidney & urinary clinical trials.

This registry tracks the long-term effects of Vanquish, a water vapor therapy for prostate cancer. It's for people who are already getting or have gotten this treatment to see how well it works over time.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
2,500 people
Ages
Any age
Study type
Observational

Who can take part

  • Your doctor must have said you're a candidate for Vanquish therapy, or you've already finished a Vanquish study.
  • You are willing and able to sign a written consent form.
  • You must not have any medical reason that makes Vanquish unsafe for you (as listed in the device's instructions).
  • You cannot have been in the VAPOR 2 study and decided not to get more Vanquish treatment.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07652164Not yet recruiting
Water vapor treatment for prostate cancer

This study tests a treatment that uses water vapor (steam) to destroy cancer cells in the prostate for men with a certain type of prostate cancer (Grade Group 3). It might be an option with fewer side effects than traditional surgery or radiation. The trial will see if this treatment works and how safe it is.

NCT06705803Recruiting
Prostate cancer ablation registry study

This study collects information from men with prostate cancer who are having or have had a procedure to destroy prostate tumors (ablation). It aims to track outcomes over time to improve future treatments.

Hyde Park, Illinois
NCT05803941Recruiting· Phase 4
Study long-term safety of a prostate cancer drug

This trial checks the long-term safety (how it affects you over time) of lutetium-177 vipivotide tetraxetan in people with prostate cancer. You may be eligible if you already received the related drug in a prior Novartis prostate cancer study and can complete the required follow-up tests.

Scottsdale, Arizona
NCT05163197Recruiting
Registry for laser treatment of localized prostate cancer

This is a registry study that collects information from men with localized prostate cancer who receive transperineal laser ablation (a procedure done through the skin between the scrotum and anus). It may help doctors better understand outcomes and refine treatment choices over time.

Amsterdam
NCT06607094Not yet recruiting
Water vapor therapy for enlarged prostate

This trial tests a treatment that uses water vapor (steam) to shrink an enlarged prostate, which can make urinating difficult. It may help if your symptoms are bothersome and other treatments haven't worked or aren't right for you.

NCT06596590Not yet recruiting
Water vapor therapy for enlarged prostate

This study tests a new treatment that uses water vapor (steam) to shrink an enlarged prostate. It may help men with moderate to severe urinary symptoms who have not had prior prostate surgery.

Nanjing, Jiangsu

Hear when a new Prostate cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.